It targets AMPK (Adenosine monophosphate activated protein kinase) and mTOR (mammalian or mechanistic target of rapamycin) molecule signaling pathways by modulating NF-κB, MMP-2 (matrix metalloproteinase-2), and MMP-9 (matrix metallopeptidase 9) proteins to regulate tumor formation [18,19,20,21]. This evidence concerns the gene MMP9 and neoplasm.